Renal pathology
Pathology
Dr. Agnes Fogo, MD
|
|
Give Review
Agnes Fogo practices Pathology. She graduated from Vanderbilt University School of Medicine. Agnes Fogo is a published doctor and has 20 publications published. The lastest was: 'Kidneys: key modulators of high-density lipoprotein levels and function.' She accepts Medicare payments and is registered with Medicare.gov.
Publications
- APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
- Decade in review-glomerular disease: The glomerulus reveals some secrets.
- Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.
- Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells.
- Hypertension is associated with preamyloid oligomers in human atrium: a missing link in atrial pathophysiology?
- Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining-reply.
- Expression of ApoESendai From Macrophages Suppresses Atherosclerosis While Causing Lipoprotein Glomerulopathy in Hyperlipidemic Mice.
- Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining.
- More light shed on light chains.
- Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts.
- Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.
- Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis.
- mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking.
- Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis?
- Specific deletion of glycogen synthase kinase-3β in the renal proximal tubule protects against acute nephrotoxic injury in mice.
- Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt.
- Animal models of regression/progression of kidney disease.
- Kidneys: key modulators of high-density lipoprotein levels and function.
- Effects of combination PPARγ agonist and angiotensin receptor blocker on glomerulosclerosis.
Schools
Vanderbilt University
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
Vanderbilt University -
Vanderbilt University School of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720186679 |
| Last Name Of The Provider | FOGO |
| First Name Of The Provider | AGNES |
| View All |
Similar Doctors
|
|
Dr. Robert E. Burnette, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cheryl M. Coffin, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alice C. Coogan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hilary H. Nickols, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fritz Parl, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mary K. Washington, MD |
|
|
Dr. David J. Switter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lin Liu, MD |
|
|
Dr. Hernan G. Correa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raina R. Flores, MD
This Doctor is OpenDoctor Recommended.
|